Log In
Print this Print this

Reyataz, atazanavir

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionHIV protease inhibitor
Molecular Target HIV protease
Mechanism of ActionViral protease inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection in antiretroviral-naïve patients; Treat HIV-1 infection; Treat HIV-1 infection in pregnant women; Treat HIV-1 infection in retroviral-naïve patients; Treat HIV/AIDS
Regulatory Designation


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today